Page last updated: 2024-08-21

2,6-dichloroindophenol and Hemoglobinopathies

2,6-dichloroindophenol has been researched along with Hemoglobinopathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paritpokee, N; Suwansaksri, J; Wiwanitkit, V1
Sangkitporn, S; Sangnoi, A; Supangwiput, O; Tanphaichitr, VS1

Other Studies

2 other study(ies) available for 2,6-dichloroindophenol and Hemoglobinopathies

ArticleYear
Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women.
    Clinical laboratory, 2002, Volume: 48, Issue:9-10

    Topics: 2,6-Dichloroindophenol; beta-Thalassemia; Electrophoresis, Cellulose Acetate; Female; Hematologic Tests; Hemoglobin E; Hemoglobinopathies; Hemoglobins, Abnormal; Humans; Mass Screening; Osmotic Fragility; Predictive Value of Tests; Pregnancy; Sensitivity and Specificity; Thailand

2002
Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
    The Southeast Asian journal of tropical medicine and public health, 2005, Volume: 36, Issue:6

    Topics: 2,6-Dichloroindophenol; Genetic Testing; Hematologic Tests; Hemoglobin E; Hemoglobinopathies; Heterozygote; Humans; Mass Screening; Polymerase Chain Reaction; Predictive Value of Tests; Sequence Analysis, DNA; Thalassemia

2005